Skip to main content
Yazan Abou-Ismail
( out of 271 reviews )

Yazan Abou-Ismail, MD

Languages spoken: Arabic, English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106

Yazan Abou-Ismail, MD (Mouhamed Yazan Abou-Ismail) is an Associate Professor of Medicine at the Division of Hematology and Hematologic Malignancies, and board-certified Hematologist and Internist. He specializes in treating non-malignant hematologic disorders, with special clinical interest in disorders of hemostasis and thrombosis, in which he has authored many peer-reviewed publications. Dr. Abou-Ismail's clinical and research interests include thrombotic microangiopathies such as thrombotic thrombocytopenic purpura, immune-mediated disorders of coagulation, as well as bleeding disorders such as von Willebrand Disease and rare blood disorders. Dr. Abou-Ismail earned his medical degree from Weill Cornell Medicine in Doha, Qatar in 2014, then completed residency training in Internal Medicine at Rochester General Hospital in Rochester, New York, followed by fellowship training in Hematology and Oncology at Case Western Reserve University, in Cleveland, OH, where he was the recipient of the 2018 Harris Foundation Award for hematology fellows. He was awarded the Faculty Teaching Award in 2022 and appointed as Associate Program Director for the University of Utah Hematology & Oncology Fellowship Program in 2023. He received the prestigious Qatar Foundation Legacy Award in 2025.

For questions regarding Dr. Abou-Ismail's practice, our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist/New Patient Coordinator at (801) 585-6906.

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)
Educational Commission for Foreign Medical Graduates

Patient Rating

Patients describe Dr. Abou-Ismail as highly knowledgeable, thorough, and skilled in managing blood disorders. Reviewers repeatedly note clear explanations in plain language, attentive listening, and a compassionate bedside manner that makes them feel heard and involved in treatment decisions. Many also praise his follow-up care and the professionalism of clinic staff.

Generated via Patient Reviews

4.9 /5
( out of 271 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


May 22, 2026
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail is an internationally renowned hematologist also specializing in clotting disorders. He is thorough, exact and detail oriented, and takes special care of his patients. I was lucky to survive a post surgery clotting disaster that nearly ended my life. Dr. Abou-Ismail has helped me navigate medications and preventative choices for a year and a half and I'm now stronger and better than before! Thank you.

May 03, 2026
SUGAR HOUSE HEALTH CENTER

Dr Abou was/is very friendly , spoke to me one on one as if we were friends but at the same time very informative and kind

Apr 10, 2026
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail is a very kind and caring doctor. He has a large amount of knowledge and resources in understanding blood disorders. He has been a great help to us!

Mar 07, 2026
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail is a fantastic provider. He cares deeply about the needs of his patients, and wants the best for them.

Mar 01, 2026
SUGAR HOUSE HEALTH CENTER

10-stars

Feb 24, 2026
SUGAR HOUSE HEALTH CENTER

He goes above and beyond to make sure he takes care of his patients between him and his team I never felt left behind he listened cared and made sure that all my questions were answered and taken care of.

Feb 09, 2026
SUGAR HOUSE HEALTH CENTER

Dr. Yazan Abou-Ismail is the very best. He combines his easy charm with a high level of knowledge and easy explanations. I'm very impressed and satisfied with our visit.

Oct 25, 2025
SUGAR HOUSE HEALTH CENTER

He's an amazing doctor that really caring about you. He takes the time to give the care you deserve. He figured out problems no doctor could explain. I'm very grateful to receive treatment from him.

Oct 18, 2025
SUGAR HOUSE HEALTH CENTER

Very knowledgeable and very caring doctor!! Excellent bed-side manners!!!!

Oct 04, 2025
SUGAR HOUSE HEALTH CENTER

Very knowledgeable

Sep 19, 2025
SUGAR HOUSE HEALTH CENTER

One word - fantastic! He is the best.

Aug 11, 2025
SUGAR HOUSE HEALTH CENTER

Dr Mouhamed Yazan Yazan Abou-Ismail is a fantastic doctor and I feel lucky that I found him for my unique case. I trust him completely!!

Jul 19, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail was awesome!! We wish every doctor was like him. He treats you like a human being and not just another patient.

Jul 06, 2025
SUGAR HOUSE HEALTH CENTER

No need to be anonymous in this post! He was very personable, professional, and knowledgeable, all wrapped up into one. I felt he very much valued my opinion and how to proceed with treatment, follow up, and feeling like I could reach out and contact him if I have any concerns. I would definitely recommend him, and all of your staff, to anyone up here in Cache Valley that needs hematological evaluation. I work for an interventional radiologist and we treat varicose veins, so I come into to contact with people that could really benefit from an evaluation for blood disorders. I will definitely be speaking with the doctor I work for this week about my experience, and have him Dr. Abou-Ismail to our patients. Thank you for everything. [NAME REMOVED]

May 31, 2025
SUGAR HOUSE HEALTH CENTER

Excellent communicator and efficient in providing up to date care for my particular situation.

May 19, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Ismail is an outstanding physician. He makes sure my medical needs are addressed. HeÕs extremely knowledgeable and at same times goes above and beyond to deliver ousting customer service and improving my experience! THE BEST.

May 03, 2025
SUGAR HOUSE HEALTH CENTER

Incredible doctor. He is compassionate, thoughtful, and seems to care quite a bit. I'm so happy I was referred to him for my healthcare.

May 02, 2025
SUGAR HOUSE HEALTH CENTER

He wanted to know about you and listened asking questioned about past health and making recommending options to medication making it my choice to stay or changed.

Apr 05, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail is an exceptionally good doctor. He is personable, easy to understand and explains things thoroughly. He offered my input and how I wanted to proceed. It was especially helpful to see charts and information graphed out, so I had a better understanding! We really appreciated his friendliness and hopeful concern!

Mar 28, 2025
SUGAR HOUSE HEALTH CENTER

Dr.Anou-Ismail is amazing truly the best. I would not go anywhere else.

Mar 14, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail is excellent. He always listens to my concerns and is informed and thorough, as well as very kind.

Jan 04, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail was very professional and kind. He was very knowledgeable and I felt comfortable talking to him.

Nov 16, 2024
SUGAR HOUSE HEALTH CENTER

Dr is very intelligent and when discussing medical issues with me, he describes it layman's terms.

Nov 06, 2024
SUGAR HOUSE HEALTH CENTER

The staff there was amazing. The physician, while nice, clearly did not care. My past team of doctors were amazing and never made me feel like I was a burden or a waste of time. This doctor did both of those in one visit. I felt like my concerns were not listened to or treated with any sort of validity. Not only that, his only focus on what could possibly be wrong was my weight. Being overweight in his eyes was the only thing wrong with me. Overweight people couldn't possibly have any other issues not caused by being fat, right? I left that appointment beyond discouraged and hating myself. I haven't been treated so poorly by a physician in a very long time. Very disappointing coming from such a large hospital organization.

Nov 01, 2024
SUGAR HOUSE HEALTH CENTER

Dr listened carefully and answered all my questions. Gave me easy and clear directions to follow.

Oct 29, 2024
SUGAR HOUSE HEALTH CENTER

Doctor Abou-Ismail is great. Very informative and cheerful. Hands down my favorite and best experience with any doctor I have ever came across.

Oct 19, 2024
SUGAR HOUSE HEALTH CENTER

Dr. Abou-Ismail truly cares about you. I feel like he treats me like a friend and a patient.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor (Clinical)
Academic Divisions Hematology & Hematologic Malignancies
Board Certification
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)
Educational Commission for Foreign Medical Graduates

Education history

Fellowship Hematology & Oncology - Case Western Reserve University Fellow
Residency Internal Medicine - Rochester General Hospital Resident
Professional Medical Medicine - Weill Cornell Medical College in Qatar M.D.
Doctoral Training Premedical Program - Weill Cornell Medical College in Qatar

Selected Publications

Journal Article

  1. Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A (2025). Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia.
  2. Abou-Ismail MY, Khalife R (2025). Navigating the challenges of neuraxial anesthesia in patients with platelet and coagulation disorders: commentary on the ISTH SSC Delphi Consensus recommendations. J Thromb Haemost, 23(6), 1771-1773.
  3. Mahmoud AA, Mostafa M, Abdelhay A, Abou-Ismail MY, Chaturvedi S (2024). Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis. Res Pract Thromb Haemost, 9(1), 102654.
  4. Lim MY, Abou-Ismail MY (2024). Double-heterozygous FVL/PTGM: double the trouble. Blood, 143(23), 2347-2349.
  5. Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Kreuziger LB, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY (2024). A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost, 8(3), 102388.
  6. Abou-Ismail MY, van der Wal DE, Cheong MA, Masten A, Blount L, Brown MC (2024). Can scientific journals benefit from a social media presence? An analysis of online traffic data and author perspectives. Res Pract Thromb Haemost, 8(3), 102387.
  7. Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY (2023). A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry. Blood Adv, 8(3), 620-623.
  8. Zafar A, Lim MY, Abou-Ismail MY (2023). Eculizumab in the management of drug-induced thrombotic microangiopathy: A scoping review of the literature. Thromb Res, 224, 73-79.
  9. Kanack AJ, Jones CG, Singh B, Leger RR, Splinter NP, Heikal NM, Pruthi RK, Chen D, George G, Abou-Ismail MY, Wool GD, Gundabolu K, Padmanabhan A (2022). Off-the-shelf Cryopreserved Platelets for the Detection of HIT and VITT Antibodies. Blood, 140(25), 2722-2729.
  10. Kanack A, Bayas A, George G, Abou-Ismail MY, Singh B, Kohlhagen M, Splinter N, Christ M, Naumann M, Moser KA, Smock KJ, Grazioli A, Wen R, Wang D, Murray DL, Padmanabhan A (2022). Monoclonal and Oligoclonal Anti-Platelet Factor 4 Antibodies Mediate VITT. Blood, 140(1), 73-77.
  11. Abou-Ismail MY, Kanack A, Splinter N, Smock KJ, Moser K, Padmanabhan A (2022). Safety of BNT162b2 mRNA Vaccine Booster in the Setting of Ad26.COV2.S-associated VITT. Blood Adv, 6, 5327-5329.
  12. Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S (2022). Does Recipient Body Mass Index Inform Donor Selection for Allogeneic Haematopoietic Cell Transplantation? Br J Haematol, 197, 326-338.
  13. Kanack AJ, Singh B, George G, Gundabolu K, Koepsell SA, Abou-Ismail MY, Moser KA, Smock KJ, Green D, Major A, Chan CW, Wool GD, Reding M, Ashrani AA, Bayas A, Grill DE, Padmanabhan A (2022). Persistence of Ad26.COV2.S-associated Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) and Specific Detection of VITT Antibodies. Am J Hematol, 97, 519-526.
  14. Thomas VM, Abou-Ismail MY, Lim MY (2021). Off-label use of Emicizumab in Persons with Acquired Haemophilia A and von Willebrand Disease: A Scoping Review of the Literature. Haemophilia, 28(1), 4-17.
  15. Abou-Ismail MY, Prchal JT, Deininger MW, Parker CJ, Lim MY (2021). Anticoagulation Management Post-transjugular Intrahepatic Portosystemic Shunt in Portal Hypertension Associated with Myeloproliferative Neoplasms. Blood Coagul Fibrinolysis, 32(8), 578-583.
  16. Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L (2020). History of Drug use in Allogeneic Hematopoietic Cell Transplant Recipients. Bone Marrow Transplant, 56(3), 581-585.
  17. Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY (2021). Acquired von Willebrand Syndrome in Monoclonal Gammopathy - A Scoping Review on Hemostatic Management. Res Pract Thromb Haemost, 5(2), 356-365.
  18. Abou-Ismail MY, Arafah Y, Fu P, Cao S, Schmaier AH, Nayak L (2020). Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab. Front Med (Lausanne), 7, 588526.
  19. Abou-Ismail MY, Vuyyala S, Prunty J, Schmaier AH, Nayak L (2020). Short Term Efficacy of Recombinant Porcine Factor VIII in Patients with Factor VIII Inhibitors. Haemophilia, 26(4), 601-606.
  20. Abou-Ismail MY, Ogunbayo GO, Secic M, Kouides PA (2017). Outgrowing the Laboratory Diagnosis of Type 1 von Willebrand Disease: A Two Decade Study. Am J Hematol, 93(2), 232-237.

Review

  1. Boothby A, Abou-Ismail MY, Sukumar S (2025). Challenges and opportunities in the long-term management of immune-mediated TTP. [Review]. Hematology Am Soc Hematol Educ Program, 2025(1), 621-627.
  2. Al-Ghafry M, Abou-Ismail MY, Acharya SS (2024). Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders. [Review]. Semin Thromb Hemost, 51(2), 227-235.
  3. Lim MY, Abou-Ismail MY, Branch DW (2022). Differentiating and Managing Rare Thrombotic Microangiopathies during Pregnancy and Postpartum. [Review]. Obstet Gynecol, 141(1), 85-108.
  4. Abou-Ismail MY, James PD, Flood VH, Connell NT (2022). Beyond the Guidelines: How we Approach Challenging Scenarios in the Diagnosis and Management of von Willebrand Disease. [Review]. J Thromb Haemost, 21(2), 204-214.
  5. Abou-Ismail MY, Kapoor S, Citla Sridhar D, Nayak L, Ahuja S (2022). Thrombotic Microangiopathies: An Illustrated Review. [Review]. Res Pract Thromb Haemost, 6(3), e12708.
  6. Abou-Ismail MY, Connell NT (2021). How to Manage Bleeding Disorders in Aging Patients Needing Surgery. [Review]. Hematology Am Soc Hematol Educ Program, 2021(1), 529-535.
  7. Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L (2020). The Hypercoagulable State in COVID-19: Incidence, Pathophysiology, and Management. [Review]. Thromb Res, 194, 101-115.
  8. Abou-Ismail MY, Citla Sridhar D, Nayak L (2020). Estrogen and Thrombosis: A Bench to Bedside Review. [Review]. Thromb Res, 192, 40-51.
  9. Citla Sridhar D, Abou-Ismail MY, Ahuja SP (2020). Central Venous Catheter-related Thrombosis in Children and Adults. [Review]. Thromb Res, 187, 103-112.

Editorial

  1. Makris M, Abou-Ismail MY (2024). Navigating the inevitable: artificial intelligence and the future of scientific communication. Res Pract Thromb Haemost, 8(5), 102538.

Letter

  1. Lim MY, Abou-Ismail MY (2021). Left Atrial Appendage Occlusion for Management of Atrial Fibrillation in Persons with Hemophilia. [Letter to the editor]. Thromb Res, 206, 9-13.
  2. Abou-Ismail MY, Moser KA, Smock KJ, Lim MY (2021). Vaccine-induced Thrombotic Thrombocytopenia following Ad26.COV2.S Vaccine in a Man Presenting as Acute Venous Thromboembolism. [Letter to the editor]. Am J Hematol, 96(9), E346-E349.